Pesquisas alternativas:
develop type » developing type (Expandir a Pesquisa)
drugs does » drugs do (Expandir a Pesquisa)
drug dev » drug deal (Expandir a Pesquisa), drug diet (Expandir a Pesquisa), drug does (Expandir a Pesquisa)
drug de » drug dose (Expandir a Pesquisa), drug dna (Expandir a Pesquisa)
develop type » developing type (Expandir a Pesquisa)
drugs does » drugs do (Expandir a Pesquisa)
drug dev » drug deal (Expandir a Pesquisa), drug diet (Expandir a Pesquisa), drug does (Expandir a Pesquisa)
drug de » drug dose (Expandir a Pesquisa), drug dna (Expandir a Pesquisa)
201
202
“... virions, respectively) and was essentially linear over a range of at least 10(4). Both wild type and drug...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
203
“...<p><strong>Background: </strong>Most of the drugs can pass to the fetus through the placenta...”
Obter o texto integral
Obter o texto integral
Artigo
204
“... in apolipoprotein B (APOB) and proprotein convertase subtilisin/kexin type 9 genes produce this phenotype. About 17...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
205
Por Vibha Jawa, Frances Terry, Jochem Gokemeijer, Shibani Mitra-Kaushik, Brian J. Roberts, Sophie Tourdot, Anne S. De Groot, Anne S. De Groot
Publicado em 2020-06-01
“...Immune responses to protein and peptide drugs can alter or reduce their efficacy and may...”Publicado em 2020-06-01
Obter o texto integral
Artigo
206
Por Lyzogubov, Valeriy V., Bora, Puran S., Wu, Xiaobo, Horn, Leah E., de Roque, Ryan, Rudolf, Xeniya V., Atkinson, John P., Bora, Nalini S.
Publicado no Am J Pathol (2016)
“... should provide valuable insights into pathogenesis and a test model system for novel drug targets. More...”Publicado no Am J Pathol (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
207
“... further the role of these drugs in the primary prevention of type 2 diabetes in patients with MetS...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
208
“...The incidence of type 2 (T2D) diabetes and other chronic conditions associated with insulin...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
209
Por Costa, Brunno Renato Farias Verçoza, Rodrigues, Juliany Cola Fernandes, Oliveira, Luiz Augusto Sousa de, Universidade Federal do Rio de Janeiro.
Publicado em 2021
Assuntos:
“...Nanopartículas de magnetita Uso terapêutico....”Publicado em 2021
Obter o texto integral
Livro
210
Por Geurts, Marlies M. E., Stewart, Roy E., Brouwers, Jacobus R. B. J., de Graeff, Pieter A., de Gier, Johan J.
Publicado no Int J Clin Pharm (2016)
“... care plan decreases the number of potential drug-related problems (DRPs) and pharmaceutical care issues...”Publicado no Int J Clin Pharm (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
211
Por McCoubrie, Joanne E., Miller, Susanne K., Sargeant, Tobias, Good, Robert T., Hodder, Anthony N., Speed, Terence P., de Koning-Ward, Tania F., Crabb, Brendan S.
Publicado em 2007
“... is to some extent further validated as a target for vaccine and drug development, our data suggest...”Publicado em 2007
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
212
Por de la Fuente-Núñez, César, Reffuveille, Fany, Mansour, Sarah C., Reckseidler-Zenteno, Shauna L., Hernández, Diego, Brackman, Gilles, Coenye, Tom, Hancock, Robert E.W.
Publicado no Chem Biol (2015)
“... derivatives. Specific D-enantiomeric peptides were the most potent at inhibiting biofilm development...”Publicado no Chem Biol (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
213
Por Elga eBernardo Bandeira De Melo, Elga eBernardo Bandeira De Melo, Miquéias eLopes-Pacheco, Miquéias eLopes-Pacheco, Nadia eChiaramoni, Débora eFerreira, Maria Julieta eFernandez-Ruocco, Maria Jimena ePrieto, Tatiana eMaron-Gutierrez, Ramiro M Perrotta, Hugo C Castro-Faria-Neto, Patricia Rieken Macedo Rocco, Silvia del Valle Alonso, Marcelo Marcos Morales
Publicado em 2016-04-01
“...Development of improved drug and gene delivery systems directly into the lungs is highly desirable...”Publicado em 2016-04-01
Obter o texto integral
Artigo
214
Por Spadola, Christine E., Wagner, Eric F., Dillon, Frank R., Trepka, Mary Jo, de La Cruz Munoz, Nestor, Messiah, Sarah E.
Publicado no Alcohol Clin Exp Res (2015)
“... risk for developing substance use problems, especially alcohol use problems. METHODS: An exhaustive...”Publicado no Alcohol Clin Exp Res (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
215
Por Green, Ezekiel, Obi, Lawrence C., Okoh, Anthony I., Nchabeleng, Maphoshane, Villiers, Babsie E. De, Letsoalo, Tomas, Hoosen, Anwar A., Bessong, Pascal O., Ndip, Roland N.
Publicado em 2013
“...% of TB cases, with 98% of death occur in developing countries. The situation in South Africa merits...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Artigo
216
Por Yanfang Feng, Nadine Händel, Marnix H. P. de Groot, Stanley Brul, Constance Schultsz, Benno H. ter Kuile
Publicado em 2014-02-01
Assuntos:
“...resistance development...”Publicado em 2014-02-01
Obter o texto integral
Artigo
217
Por Paglialunga, Sabina, Morimoto, Bruce H., de la Peña, Amparo, Fortier, Caroline
Publicado no Clin Pharmacol Drug Dev (2018)
“... of studies have utilized CGM in type 2 diabetes mellitus (T2DM) drug development. A potential barrier from...”Publicado no Clin Pharmacol Drug Dev (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
218
Por Paredes-Juarez, Genaro A., de Vos, Paul, Bulte, Jeff W.M.
Publicado no Expert Rev Precis Med Drug Dev (2017)
“...INTRODUCTION: Type 1 diabetes mellitus (T1DM) is an autoimmune disease in which the pancreas...”Publicado no Expert Rev Precis Med Drug Dev (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
219
Por Szwarcwald, Célia Landmann, Damacena, Giseli Nogueira, de Souza-Júnior, Paulo Roberto Borges, Guimarães, Mark Drew Crosland, de Almeida, Wanessa da Silva, de Souza Ferreira, Arthur Pate, Ferreira-Júnior, Orlando da Costa, Dourado, Inês
Publicado no Medicine (Baltimore) (2018)
“... of violence, alcohol and drug use, utilization of health services, and occurrence of other sexually...”Publicado no Medicine (Baltimore) (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
220
Por Qintar, Mohammed, Chhatriwalla, Adnan K., Arnold, Suzanne V., Tang, Fengming, Buchanan, Donna M., Shafiq, Ali, Pokharel, Yashashwi, deBronkart, Dave, Ashraf, Javed M., Spertus, John A.
Publicado no Catheter Cardiovasc Interv (2017)
“.... BACKGROUND: Drug eluting stents (DES) markedly reduce the risk of repeat percutaneous coronary intervention...”Publicado no Catheter Cardiovasc Interv (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo